NAT10 inhibition alleviates astrocyte autophagy by impeding ac4C acetylation of Timp1 mRNA in ischemic stroke
Although a single nucleotide polymorphism for N-acetyltransferase 10 (NAT10) has been identified in patients with early-onset stroke, the role of NAT10 in ischemic injury and the related underlying mechanisms remains elusive. Here, we provide evidence that NAT10, the only known RNA N4-acetylcytidine...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Acta Pharmaceutica Sinica B |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383525001820 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849321392925835264 |
|---|---|
| author | Li Yang Xiaotong Li Yaxuan Zhao Hao Chen Can Wang Angrong Wu Xintong Guo Yue Huang Qihui Wang Lingyun Hao Xiaowen Li Ying Ji Jin Ban Guangtian Wang Junli Cao Zhiqiang Pan |
| author_facet | Li Yang Xiaotong Li Yaxuan Zhao Hao Chen Can Wang Angrong Wu Xintong Guo Yue Huang Qihui Wang Lingyun Hao Xiaowen Li Ying Ji Jin Ban Guangtian Wang Junli Cao Zhiqiang Pan |
| author_sort | Li Yang |
| collection | DOAJ |
| description | Although a single nucleotide polymorphism for N-acetyltransferase 10 (NAT10) has been identified in patients with early-onset stroke, the role of NAT10 in ischemic injury and the related underlying mechanisms remains elusive. Here, we provide evidence that NAT10, the only known RNA N4-acetylcytidine (ac4C) modification “writer”, is increased in the damaged cortex of patients with acute ischemic stroke and the peri-infarct cortex of mice subjected to photothrombotic (PT) stroke. Pharmacological inhibition of NAT10 with remodelin on Days 3–7 post-stroke or astrocytic depletion of NAT10 via targeted virus attenuates ischemia-induced infarction and improves functional recovery in PT mice. Mechanistically, NAT10 enhances ac4C acetylation of the inflammatory cytokine tissue inhibitor of metalloproteinase 1 (Timp1) mRNA transcript, which increases TIMP1 expression and results in the accumulation of microtubule-associated protein 1 light chain 3 (LC3) and progression of astrocyte autophagy. These findings demonstrate that NAT10 regulates astrocyte autophagy by targeting Timp1 ac4C after stroke. This study highlights the critical role of ac4C in the regulation of astrocyte autophagy and proposes a promising strategy to improve post-stroke outcomes via NAT10 inhibition. |
| format | Article |
| id | doaj-art-c3829253bfab4c718d371d60bf690dc1 |
| institution | Kabale University |
| issn | 2211-3835 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Acta Pharmaceutica Sinica B |
| spelling | doaj-art-c3829253bfab4c718d371d60bf690dc12025-08-20T03:49:45ZengElsevierActa Pharmaceutica Sinica B2211-38352025-05-011552575259210.1016/j.apsb.2025.03.042NAT10 inhibition alleviates astrocyte autophagy by impeding ac4C acetylation of Timp1 mRNA in ischemic strokeLi Yang0Xiaotong Li1Yaxuan Zhao2Hao Chen3Can Wang4Angrong Wu5Xintong Guo6Yue Huang7Qihui Wang8Lingyun Hao9Xiaowen Li10Ying Ji11Jin Ban12Guangtian Wang13Junli Cao14Zhiqiang Pan15Jiangsu Province Key Laboratory of Anesthesiology, Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, National Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, Xuzhou Medical University, Xuzhou 221004, China; Corresponding authors.Jiangsu Province Key Laboratory of Anesthesiology, Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, National Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, Xuzhou Medical University, Xuzhou 221004, ChinaJiangsu Province Key Laboratory of Anesthesiology, Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, National Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, Xuzhou Medical University, Xuzhou 221004, ChinaDepartment of Neurology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, ChinaJiangsu Province Key Laboratory of Anesthesiology, Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, National Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, Xuzhou Medical University, Xuzhou 221004, ChinaJiangsu Province Key Laboratory of Anesthesiology, Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, National Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, Xuzhou Medical University, Xuzhou 221004, ChinaJiangsu Province Key Laboratory of Anesthesiology, Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, National Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, Xuzhou Medical University, Xuzhou 221004, ChinaJiangsu Province Key Laboratory of Anesthesiology, Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, National Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, Xuzhou Medical University, Xuzhou 221004, ChinaJiangsu Province Key Laboratory of Anesthesiology, Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, National Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, Xuzhou Medical University, Xuzhou 221004, ChinaJiangsu Province Key Laboratory of Anesthesiology, Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, National Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, Xuzhou Medical University, Xuzhou 221004, ChinaDepartment of Neurology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, ChinaDepartment of Neurology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, ChinaDepartment of Neurology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, ChinaTeaching Center of Pathogenic Biology, School of Basic Medical Sciences, Harbin Medical University, Harbin 150081, ChinaJiangsu Province Key Laboratory of Anesthesiology, Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, National Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, Xuzhou Medical University, Xuzhou 221004, China; Corresponding authors.Jiangsu Province Key Laboratory of Anesthesiology, Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, National Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, Xuzhou Medical University, Xuzhou 221004, China; Corresponding authors.Although a single nucleotide polymorphism for N-acetyltransferase 10 (NAT10) has been identified in patients with early-onset stroke, the role of NAT10 in ischemic injury and the related underlying mechanisms remains elusive. Here, we provide evidence that NAT10, the only known RNA N4-acetylcytidine (ac4C) modification “writer”, is increased in the damaged cortex of patients with acute ischemic stroke and the peri-infarct cortex of mice subjected to photothrombotic (PT) stroke. Pharmacological inhibition of NAT10 with remodelin on Days 3–7 post-stroke or astrocytic depletion of NAT10 via targeted virus attenuates ischemia-induced infarction and improves functional recovery in PT mice. Mechanistically, NAT10 enhances ac4C acetylation of the inflammatory cytokine tissue inhibitor of metalloproteinase 1 (Timp1) mRNA transcript, which increases TIMP1 expression and results in the accumulation of microtubule-associated protein 1 light chain 3 (LC3) and progression of astrocyte autophagy. These findings demonstrate that NAT10 regulates astrocyte autophagy by targeting Timp1 ac4C after stroke. This study highlights the critical role of ac4C in the regulation of astrocyte autophagy and proposes a promising strategy to improve post-stroke outcomes via NAT10 inhibition.http://www.sciencedirect.com/science/article/pii/S2211383525001820Ischemic strokeac4CNAT10Timp1NeuroprotectionFunctional recovery |
| spellingShingle | Li Yang Xiaotong Li Yaxuan Zhao Hao Chen Can Wang Angrong Wu Xintong Guo Yue Huang Qihui Wang Lingyun Hao Xiaowen Li Ying Ji Jin Ban Guangtian Wang Junli Cao Zhiqiang Pan NAT10 inhibition alleviates astrocyte autophagy by impeding ac4C acetylation of Timp1 mRNA in ischemic stroke Acta Pharmaceutica Sinica B Ischemic stroke ac4C NAT10 Timp1 Neuroprotection Functional recovery |
| title | NAT10 inhibition alleviates astrocyte autophagy by impeding ac4C acetylation of Timp1 mRNA in ischemic stroke |
| title_full | NAT10 inhibition alleviates astrocyte autophagy by impeding ac4C acetylation of Timp1 mRNA in ischemic stroke |
| title_fullStr | NAT10 inhibition alleviates astrocyte autophagy by impeding ac4C acetylation of Timp1 mRNA in ischemic stroke |
| title_full_unstemmed | NAT10 inhibition alleviates astrocyte autophagy by impeding ac4C acetylation of Timp1 mRNA in ischemic stroke |
| title_short | NAT10 inhibition alleviates astrocyte autophagy by impeding ac4C acetylation of Timp1 mRNA in ischemic stroke |
| title_sort | nat10 inhibition alleviates astrocyte autophagy by impeding ac4c acetylation of timp1 mrna in ischemic stroke |
| topic | Ischemic stroke ac4C NAT10 Timp1 Neuroprotection Functional recovery |
| url | http://www.sciencedirect.com/science/article/pii/S2211383525001820 |
| work_keys_str_mv | AT liyang nat10inhibitionalleviatesastrocyteautophagybyimpedingac4cacetylationoftimp1mrnainischemicstroke AT xiaotongli nat10inhibitionalleviatesastrocyteautophagybyimpedingac4cacetylationoftimp1mrnainischemicstroke AT yaxuanzhao nat10inhibitionalleviatesastrocyteautophagybyimpedingac4cacetylationoftimp1mrnainischemicstroke AT haochen nat10inhibitionalleviatesastrocyteautophagybyimpedingac4cacetylationoftimp1mrnainischemicstroke AT canwang nat10inhibitionalleviatesastrocyteautophagybyimpedingac4cacetylationoftimp1mrnainischemicstroke AT angrongwu nat10inhibitionalleviatesastrocyteautophagybyimpedingac4cacetylationoftimp1mrnainischemicstroke AT xintongguo nat10inhibitionalleviatesastrocyteautophagybyimpedingac4cacetylationoftimp1mrnainischemicstroke AT yuehuang nat10inhibitionalleviatesastrocyteautophagybyimpedingac4cacetylationoftimp1mrnainischemicstroke AT qihuiwang nat10inhibitionalleviatesastrocyteautophagybyimpedingac4cacetylationoftimp1mrnainischemicstroke AT lingyunhao nat10inhibitionalleviatesastrocyteautophagybyimpedingac4cacetylationoftimp1mrnainischemicstroke AT xiaowenli nat10inhibitionalleviatesastrocyteautophagybyimpedingac4cacetylationoftimp1mrnainischemicstroke AT yingji nat10inhibitionalleviatesastrocyteautophagybyimpedingac4cacetylationoftimp1mrnainischemicstroke AT jinban nat10inhibitionalleviatesastrocyteautophagybyimpedingac4cacetylationoftimp1mrnainischemicstroke AT guangtianwang nat10inhibitionalleviatesastrocyteautophagybyimpedingac4cacetylationoftimp1mrnainischemicstroke AT junlicao nat10inhibitionalleviatesastrocyteautophagybyimpedingac4cacetylationoftimp1mrnainischemicstroke AT zhiqiangpan nat10inhibitionalleviatesastrocyteautophagybyimpedingac4cacetylationoftimp1mrnainischemicstroke |